Literature DB >> 15390353

Congenital cervical neuroblastoma.

Teresa M Cardesa-Salzmann1, Jaume Mora-Graupera, Gemma Claret, Thais Agut.   

Abstract

Primary congenital cervical neuroblastomas are very rare. A history of upper aerodigestive compromise with Horner syndrome can be of value for the early diagnosis of this lesion. Congenital neuroblastomas usually have a favorable outcome. Like all the other clinically relevant groups of neuroblastomas, management should take into consideration the biological findings of each tumor, which predicts outcome than other clinical findings. 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15390353     DOI: 10.1002/pbc.20190

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  5 in total

1.  Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project.

Authors:  Kieuhoa T Vo; Katherine K Matthay; John Neuhaus; Wendy B London; Barbara Hero; Peter F Ambros; Akira Nakagawara; Doug Miniati; Kate Wheeler; Andrew D J Pearson; Susan L Cohn; Steven G DuBois
Journal:  J Clin Oncol       Date:  2014-08-25       Impact factor: 44.544

Review 2.  Retropharyngeal neuroblastoma in a neonate: case report and literature review.

Authors:  Tadaharu Okazaki; Masaaki Ohshita; Masayuki Furukawa; Katsuhisa Ikeda; Yutaka Ozaki; Geoffrey J Lane; Atsuyuki Yamataka
Journal:  Pediatr Surg Int       Date:  2007-10       Impact factor: 1.827

3.  Management of oropharyngeal teratoma: Two case reports and a literature review.

Authors:  Peng Zhu; Xiao-Yan Li
Journal:  J Int Med Res       Date:  2021-02       Impact factor: 1.671

4.  Congenital or acquired Horner's?

Authors:  Ketki Toprani; Shashikant Shetty; P Vijayalakshmi
Journal:  Indian J Ophthalmol       Date:  2007 Sep-Oct       Impact factor: 1.848

5.  Paediatric Horner Syndrome: How much further to investigate?

Authors:  Manjushree Bhate; Maree Flaherty; Neil Rowe; Robert Howman-Giles
Journal:  Indian J Ophthalmol       Date:  2020-11       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.